Biomark Diagnostics (XCNQ:BUX) Net Income (Continuing Operations) : C$-1.90 Mil (TTM As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Biomark Diagnostics's Net Income (Continuing Operations) for the three months ended in Dec. 2024 was C$-0.34 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 was C$-1.90 Mil.

Biomark Diagnostics Net Income (Continuing Operations) Historical Data

The historical data trend for Biomark Diagnostics's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Net Income (Continuing Operations) Chart

Biomark Diagnostics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-1.22

-1.09

-1.45

-1.84

-1.43

Biomark Diagnostics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-0.41	-0.39	-0.62	-0.55	-0.34

Biomark Diagnostics Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.90 Mil.

Biomark Diagnostics (XCNQ:BUX) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Biomark Diagnostics Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (XCNQ:BUX) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

BMKDF:USA 20B:Germany

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.

Executives

Rashid Ahmed Maula Bux	Director
Guoyu Huang	Senior Officer

Biomark Diagnostics Headlines

No Headlines